Less than a couple of weeks after launching its equity crowdfunding campaign on Crowdcube, UK-based feminine care product company Callaly has successfully raised nearly £1.3 million in funding. The company quickly raised its initial £1 million funding target at the end of June. It is now offering 6.54% in equity at an £18,349,998 pre-money valuation.
As previously reported, Callaly describes itself as a new British femcare company based in London named one of the “period-positive startups” revolutionizing the multi-billion pound feminine care industry by the Independent and one of the UK’s 50 leading D2C companies by the IAB. The company further explained:
“Since the tampon became available in the 1930s, its design has remained largely unaltered – despite most women needing to use a separate liner ‘just in case’. We thought it was time for a change, so we’ve launched the Tampliner, the first patented product to completely rethink how a tampon could work.”
Callaly also noted The Tampliner has received multiple industry innovation awards and is manufactured in the UK. The Tampliner is multi-patented in 30 countries (with potential for IVF/medicine delivery) and Callaly has developed bespoke robotic machinery to automate production at a UK facility. Speaking further about its history, Callaly stated:
“We are actively building a team of dynamic, hard-working and fun team players, all keen to deliver exceptional products driven by purpose and without compromise. We are a certified B Corporation, with part of our profits helping to improve quality of life and access to healthcare for people with periods around the world.”
Funds from the Crowdcube round will be used to continue the growth and development of the company and its products. The campaign is set to close at the beginning of August.
Have a crowdfunding offering you'd like to share? Submit an offering for consideration using our Submit a Tip form and we may share it on our site!
